Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

Completed

• Conditions: Dyslipidemias

• Registration Number: NCT00931320
• Lead Sponsor: AstraZeneca

Brief Summary

An observational, non-interventional, multi-centre study to provide further information on the ratio of LDL-C to HDL-C improvement after statin treatment in Korean patients group.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-06-30
• Study Start: 2009-07
• Study First Submitted QC: 2009-07-01
• Study First Posted: 2009-07-02
• Study Completion: 2009-09
• Status Verified: 2009-10
• Last Update Submitted: 2009-10-23
• Last Update Posted: 2009-10-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

• Subjects who are taking lipid-lowering medication after diagnosed as dyslipidaemia
• Subjects who have at least made 1 visit to the outpatient clinic within previous 6 months
• Subjects who have records of both LDL-C and HDL-C before & after statin treatment (at least four weeks after statin taking)

Exclusion Criteria

• Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate current LDL/HDL ratio in Korean patients (between baseline & after treatment)	After Treatment : at least 4 weeks before statin taking /Baseline : no limitation.

Secondary Outcome Measures

Name	Time	Method
Evaluate difference of LDL/HDL ratio among different statins & dosages (between baseline & after treatment)	After Treatment : at least 4 weeks before statin taking / Baseline : no limitation.